Infectious Disease In Vitro Diagnostics Market Report Infographic Image

Published : March 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Infectious Disease In Vitro Diagnostics Market Report 2026

Name: Infectious Disease In Vitro Diagnostics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product Type (Instruments, Reagents, Software And Services), By Technology (Molecular Diagnostics, Immunoassay, Microbiology), By Application (Methicillin-Resistant Staphylococcus Aureus (MRSA), Clostridium Difficile, Respiratory Virus, Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB), Gonorrhea, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Hepatitis C, Hepatitis B, Other Applications), By End-Use (Hospitals And Clinics, Diagnostic Laboratories, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Infectious Disease In Vitro Diagnostics Market Overview

• Infectious Disease In Vitro Diagnostics market size has reached to $15.1 billion in 2025

• Expected to grow to $21.25 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%

• Growth Driver: Surge In Global Prevalence Of Infectious Diseases Fueled The Market Growth Due To Increased Demand For Effective Diagnostic Solutions

• Market Trend: Developing Rapid Multi-Pathogen Detection Solutions To Enhance Timely Diagnosis And Expand Point-Of-Care Testing

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Infectious Disease In Vitro Diagnostics Market?

Infectious disease in vitro diagnostics refers to laboratory-based tests performed on samples such as blood, urine, or swabs to detect, identify, and monitor infectious pathogens, including bacteria, viruses, fungi, and parasites. These diagnostics help to provide accurate and timely diagnosis, guide treatment decisions, and support disease surveillance and infection control measures.

The main product types of infectious disease in vitro diagnostics are instruments, reagents, and software and services. Instruments refer to tools or devices used to measure and monitor environmental conditions such as air, water, soil, and noise. It utilizes various technologies such as molecular diagnostics, immunoassay, microbiology, hematology, urinalysis, and others. It finds application in methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile, respiratory virus, tuberculosis (TB) and drug-resistant TB, gonorrhea, human papillomavirus (HPV), human immunodeficiency virus (HIV), hepatitis C, hepatitis B, and others, serving end-users such as hospitals and clinics, diagnostic laboratories, academic research institutes, and others.

Infectious Disease In Vitro Diagnostics market report bar graph

What Is The Infectious Disease In Vitro Diagnostics Market Size and Share 2026?

The infectious disease in vitro diagnostics market size has grown strongly in recent years. It will grow from $15.1 billion in 2025 to $16.13 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to global infectious disease burden, hospital laboratory expansion, demand for early diagnosis, advances in immunoassays, government disease control programs.

What Is The Infectious Disease In Vitro Diagnostics Market Growth Forecast?

The infectious disease in vitro diagnostics market size is expected to see strong growth in the next few years. It will grow to $21.25 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to pandemic preparedness initiatives, growth in molecular diagnostics, rising antimicrobial resistance, expansion of diagnostic labs, increased healthcare screening. Major trends in the forecast period include rapid molecular diagnostic adoption, point of care infectious testing, high sensitivity pathogen detection, multiplex diagnostic panels, increased surveillance testing.

Book your 30 minutes free consultation with our research experts

Global Infectious Disease In Vitro Diagnostics Market Segmentation

1) By Product Type: Instruments, Reagents, Software And Services

2) By Technology: Molecular Diagnostics, Immunoassay, Microbiology

3) By Application: Methicillin-Resistant Staphylococcus Aureus (MRSA), Clostridium Difficile, Respiratory Virus, Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB), Gonorrhea, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Hepatitis C, Hepatitis B, Other Applications

4) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Instrument: Polymerase Chain Reaction Machines, Immunoassay Analyzers, Microbiology Analyzers, Next Generation Sequencers

2) By Reagent: Molecular Reagents, Immunoassay Reagents, Microbiology Reagents, Enzymes And Buffers, Controls And Calibrators

3) By Software And Services: Data Management Software, Laboratory Information Systems, Cloud Based Solutions, Maintenance And Support Services, Consulting And Training Services

What Is The Driver Of The Infectious Disease In Vitro Diagnostics Market?

The increased global prevalence of infectious diseases fueled the growth of the infectious disease in vitro diagnostics market during the historic period. Infectious diseases refer to the individuals affected by bacterial, viral, fungal, or parasitic infections worldwide at a specific point in time, indicating the overall disease burden within populations. Climate change has expanded the habitats of disease-carrying vectors such as mosquitoes, leading to a rise in the global prevalence of infectious diseases. The infectious disease in vitro diagnostics support this trend by providing precise and timely diagnostic tools that enable healthcare providers to identify pathogens, initiate appropriate treatment, and contain outbreaks more effectively. For instance, in October 2024, according to the World Health Organization, a Switzerland-based health authority, approximately 10.8 million people worldwide contracted tuberculosis, with 55% being men, 33% women, and 12% children and adolescents, and individuals living with human immunodeficiency virus (HIV) representing 6.1% of cases. Therefore, the increasing global prevalence of infectious diseases fueled the growth of the infectious disease in vitro diagnostics industry during the historic period.

Key Players In The Global Infectious Disease In Vitro Diagnostics Market

Major companies operating in the infectious disease in vitro diagnostics market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, bioMérieux SA, QIAGEN N.V., Becton Dickinson and Company, Hologic Inc., DiaSorin S.p.A., Meridian Bioscience, Quidel Corporation, Revvity Inc., OraSure Technologies Inc., Transasia Bio-Medicals Ltd., Randox Laboratories, Luminex Corporation, Wako Pure Chemical Industries Ltd., Bio-Rad Laboratories Inc., Trivitron Healthcare

Global Infectious Disease In Vitro Diagnostics Market Trends and Insights

Major companies operating in the infectious disease in vitro diagnostics market are focusing on developing innovative products, such as rapid detection of multiple gastrointestinal pathogens, to enable timely diagnosis, improve patient outcomes, and expand point-of-care testing capabilities. Rapid detection of multiple gastrointestinal pathogens refers to diagnostic tests that can quickly identify the presence of several disease-causing microorganisms in the gastrointestinal tract from a single sample. For instance, in June 2024, MP Biomedicals, a US-based provider of a diverse range of products, chemicals, and diagnostics, launched a range of immunochromatographic-based rapid diagnostic kits for gastrointestinal infectious diseases. These enable quick and accurate detection of Helicobacter pylori, Salmonella typhi, and Vibrio cholerae serogroups O1 and O139. These kits feature rapid, point-of-care qualitative detection, versatile sample use (stool, blood, plasma, serum, water, and food), and suitability for both clinical and research settings. Leveraging cutting-edge immunochromatographic technology, they support early diagnosis, monitoring of treatment effectiveness, and confirmation of pathogen eradication, representing a significant advancement in gastrointestinal health diagnostics by combining speed, precision, and broad pathogen coverage.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Infectious Disease In Vitro Diagnostics Market?

In January 2025, Fremman Capital, a UK-based private equity firm specializing in healthcare and life sciences investments, acquired a majority stake in DIESSE Diagnostica Senese for an undisclosed amount. With this acquisition, Fremman Capital aims to accelerate DIESSE’s international expansion and strengthen its position as a leader in the specialty in vitro diagnostics market by supporting innovation, broadening the product portfolio for autoimmune and infectious disease diagnostics, and enhancing production capacities at DIESSE’s advanced biotech campus, thereby driving long-term sustainable growth. DIESSE Diagnostica Senese is an Italy-based producer of innovative in vitro diagnostics and reagents focused on autoimmunity, infectious diseases, and hematological testing, serving clinical laboratories globally.

Regional Outlook

North America was the largest region in the infectious disease in vitro diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Infectious Disease In Vitro Diagnostics Market?

The infectious disease in vitro diagnostics market consists of revenues earned by entities by providing services such as serology testing, rapid diagnostic testing, disease surveillance and monitoring, sample collection and processing, and consulting and training services. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease in vitro diagnostics market also includes sales of rapid test kits, culture media, controls and calibrators, molecular sequencing kits, flow cytometry reagents, and point-of-care diagnostic devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Infectious Disease In Vitro Diagnostics Market Report 2026?

The infectious disease in vitro diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the infectious disease in vitro diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Infectious Disease In Vitro Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$16.13 billion
Revenue Forecast In 2035	$21.25 billion
Growth Rate	CAGR of 6.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product Type, Technology, Application, End-Use
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, bioMérieux SA, QIAGEN N.V., Becton Dickinson and Company, Hologic Inc., DiaSorin S.p.A., Meridian Bioscience, Quidel Corporation, Revvity Inc., OraSure Technologies Inc., Transasia Bio-Medicals Ltd., Randox Laboratories, Luminex Corporation, Wako Pure Chemical Industries Ltd., Bio-Rad Laboratories Inc., Trivitron Healthcare
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Infectious Disease In Vitro Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Infectious Disease In Vitro Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Infectious Disease In Vitro Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Infectious Disease In Vitro Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rapid Molecular Diagnostic Adoption

4.2.2 Point Of Care Infectious Testing

4.2.3 High Sensitivity Pathogen Detection

4.2.4 Multiplex Diagnostic Panels

4.2.5 Increased Surveillance Testing

5. Infectious Disease In Vitro Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Diagnostic Laboratories

5.3 Academic Research Institutes

5.4 Public Health Laboratories

5.5 Reference Laboratories

6. Infectious Disease In Vitro Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Infectious Disease In Vitro Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Infectious Disease In Vitro Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Infectious Disease In Vitro Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Infectious Disease In Vitro Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Infectious Disease In Vitro Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Infectious Disease In Vitro Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Infectious Disease In Vitro Diagnostics Market Segmentation

9.1. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Instruments, Reagents, Software And Services

9.2. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Molecular Diagnostics, Immunoassay, Microbiology

9.3. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Methicillin-Resistant Staphylococcus Aureus (MRSA), Clostridium Difficile, Respiratory Virus, Tuberculosis (TB) And Drug-Resistant Tuberculosis (TB), Gonorrhea, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Hepatitis C, Hepatitis B, Other Applications

9.4. Global Infectious Disease In Vitro Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Diagnostic Laboratories, Other End-Users

9.5. Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction Machines, Immunoassay Analyzers, Microbiology Analyzers, Next Generation Sequencers

9.6. Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Molecular Reagents, Immunoassay Reagents, Microbiology Reagents, Enzymes And Buffers, Controls And Calibrators

9.7. Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Data Management Software, Laboratory Information Systems, Cloud Based Solutions, Maintenance And Support Services, Consulting And Training Services

10. Infectious Disease In Vitro Diagnostics Market Regional And Country Analysis

10.1. Global Infectious Disease In Vitro Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Infectious Disease In Vitro Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Infectious Disease In Vitro Diagnostics Market

11.1. Asia-Pacific Infectious Disease In Vitro Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Infectious Disease In Vitro Diagnostics Market

12.1. China Infectious Disease In Vitro Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Infectious Disease In Vitro Diagnostics Market

13.1. India Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Infectious Disease In Vitro Diagnostics Market

14.1. Japan Infectious Disease In Vitro Diagnostics Market Overview

14.2. Japan Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Infectious Disease In Vitro Diagnostics Market

15.1. Australia Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Infectious Disease In Vitro Diagnostics Market

16.1. Indonesia Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Infectious Disease In Vitro Diagnostics Market

17.1. South Korea Infectious Disease In Vitro Diagnostics Market Overview

17.2. South Korea Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Infectious Disease In Vitro Diagnostics Market

18.1. Taiwan Infectious Disease In Vitro Diagnostics Market Overview

18.2. Taiwan Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Infectious Disease In Vitro Diagnostics Market

19.1. South East Asia Infectious Disease In Vitro Diagnostics Market Overview

19.2. South East Asia Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Infectious Disease In Vitro Diagnostics Market

20.1. Western Europe Infectious Disease In Vitro Diagnostics Market Overview

20.2. Western Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Infectious Disease In Vitro Diagnostics Market

21.1. UK Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Infectious Disease In Vitro Diagnostics Market

22.1. Germany Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Infectious Disease In Vitro Diagnostics Market

23.1. France Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Infectious Disease In Vitro Diagnostics Market

24.1. Italy Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Infectious Disease In Vitro Diagnostics Market

25.1. Spain Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Infectious Disease In Vitro Diagnostics Market

26.1. Eastern Europe Infectious Disease In Vitro Diagnostics Market Overview

26.2. Eastern Europe Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Infectious Disease In Vitro Diagnostics Market

27.1. Russia Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Infectious Disease In Vitro Diagnostics Market

28.1. North America Infectious Disease In Vitro Diagnostics Market Overview

28.2. North America Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Infectious Disease In Vitro Diagnostics Market

29.1. USA Infectious Disease In Vitro Diagnostics Market Overview

29.2. USA Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Infectious Disease In Vitro Diagnostics Market

30.1. Canada Infectious Disease In Vitro Diagnostics Market Overview

30.2. Canada Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Infectious Disease In Vitro Diagnostics Market

31.1. South America Infectious Disease In Vitro Diagnostics Market Overview

31.2. South America Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Infectious Disease In Vitro Diagnostics Market

32.1. Brazil Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Infectious Disease In Vitro Diagnostics Market

33.1. Middle East Infectious Disease In Vitro Diagnostics Market Overview

33.2. Middle East Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Infectious Disease In Vitro Diagnostics Market

34.1. Africa Infectious Disease In Vitro Diagnostics Market Overview

34.2. Africa Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Infectious Disease In Vitro Diagnostics Market Regulatory and Investment Landscape

36. Infectious Disease In Vitro Diagnostics Market Competitive Landscape And Company Profiles

36.1. Infectious Disease In Vitro Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Infectious Disease In Vitro Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Infectious Disease In Vitro Diagnostics Market Company Profiles

36.3.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Siemens Healthcare AG Overview, Products and Services, Strategy and Financial Analysis

37. Infectious Disease In Vitro Diagnostics Market Other Major And Innovative Companies

bioMérieux SA, QIAGEN N.V., Becton, Dickinson and Company, Hologic Inc., DiaSorin S.p.A., Meridian Bioscience, Quidel Corporation, Revvity Inc., OraSure Technologies Inc., Transasia Bio-Medicals Ltd., Randox Laboratories, Luminex Corporation, Wako Pure Chemical Industries Ltd., Bio-Rad Laboratories Inc., Trivitron Healthcare

38. Global Infectious Disease In Vitro Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Infectious Disease In Vitro Diagnostics Market

40. Infectious Disease In Vitro Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Infectious Disease In Vitro Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Infectious Disease In Vitro Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Infectious Disease In Vitro Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Infectious Disease In Vitro Diagnostics Market, Overview Of Key Products - Product Examples

Table 2: Global Infectious Disease In Vitro Diagnostics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Infectious Disease In Vitro Diagnostics Market, Supply Chain Analysis

Table 4: Global Infectious Disease In Vitro Diagnostics Market, Major Raw Material Providers

Table 5: Global Infectious Disease In Vitro Diagnostics Market, Major Resource Providers

Table 6: Global Infectious Disease In Vitro Diagnostics Market, Major Manufacturers (Suppliers)

Table 7: Global Infectious Disease In Vitro Diagnostics Market, Major Distributors And Channel Partners

Table 8: Global Infectious Disease In Vitro Diagnostics Market, Key Technologies & Future Trends

Table 9: Global Infectious Disease In Vitro Diagnostics Market, Major Trends

Table 10: Global Infectious Disease In Vitro Diagnostics Market, Major End Users

Table 11: Global Infectious Disease In Vitro Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Infectious Disease In Vitro Diagnostics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Infectious Disease In Vitro Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Infectious Disease In Vitro Diagnostics Market - TAM, US$ Billion, 2025

Table 15: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Infectious Disease In Vitro Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Infectious Disease In Vitro Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Infectious Disease In Vitro Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Infectious Disease In Vitro Diagnostics Market - Company Scoring Matrix

Table 98: F. Hoffmann-La Roche AG Financial Performance

Table 99: Abbott Laboratories Financial Performance

Table 100: Danaher Corporation Financial Performance

Table 101: Thermo Fisher Scientific Inc. Financial Performance

Table 102: Siemens Healthcare AG Financial Performance

Table 103: Global Infectious Disease In Vitro Diagnostics Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Infectious Disease In Vitro Diagnostics Market, Competitive Dashboard

Table 105: Global Infectious Disease In Vitro Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Infectious Disease In Vitro Diagnostics Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Table 107: Global, Infectious Disease In Vitro Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 108: Global, Infectious Disease In Vitro Diagnostics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Infectious Disease In Vitro Diagnostics Market, Overview Of Key Products - Product Examples

Figure 2: Global Infectious Disease In Vitro Diagnostics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Infectious Disease In Vitro Diagnostics Market, Supply Chain Analysis

Figure 4: Global Infectious Disease In Vitro Diagnostics Market, Major Raw Material Providers

Figure 5: Global Infectious Disease In Vitro Diagnostics Market, Major Resource Providers

Figure 6: Global Infectious Disease In Vitro Diagnostics Market, Major Manufacturers (Suppliers)

Figure 7: Global Infectious Disease In Vitro Diagnostics Market, Major Distributors And Channel Partners

Figure 8: Global Infectious Disease In Vitro Diagnostics Market, Key Technologies & Future Trends

Figure 9: Global Infectious Disease In Vitro Diagnostics Market, Major Trends

Figure 10: Global Infectious Disease In Vitro Diagnostics Market, Major End Users

Figure 11: Global Infectious Disease In Vitro Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Infectious Disease In Vitro Diagnostics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Infectious Disease In Vitro Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Infectious Disease In Vitro Diagnostics Market - TAM, US$ Billion, 2025

Figure 15: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Infectious Disease In Vitro Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Infectious Disease In Vitro Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Infectious Disease In Vitro Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Infectious Disease In Vitro Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Infectious Disease In Vitro Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Infectious Disease In Vitro Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Infectious Disease In Vitro Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Infectious Disease In Vitro Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Infectious Disease In Vitro Diagnostics Market - Company Scoring Matrix

Figure 98: F. Hoffmann-La Roche AG Financial Performance

Figure 99: Abbott Laboratories Financial Performance

Figure 100: Danaher Corporation Financial Performance

Figure 101: Thermo Fisher Scientific Inc. Financial Performance

Figure 102: Siemens Healthcare AG Financial Performance

Figure 103: Global Infectious Disease In Vitro Diagnostics Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Infectious Disease In Vitro Diagnostics Market, Competitive Dashboard

Figure 105: Global Infectious Disease In Vitro Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Infectious Disease In Vitro Diagnostics Market Size Gain ($ Billion), Segmentation By Product Type, 2025 – 2030

Figure 107: Global, Infectious Disease In Vitro Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 108: Global, Infectious Disease In Vitro Diagnostics Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

Latest Market Developments in Aseptic Connectors And Welders Industry: Forecast 2025–2029

Competitive and Market Trend Analysis of Atrial Fibrillation Devices Industry Through 2029

Industry Trends Show Bioabsorbable Surgical Mesh Market Set to Expand at 8.6% CAGR Until 2029

Strategic Report on Biodegradable Hemostat Market: Growth Opportunities and Emerging Challenges

Infectious Disease Diagnostics Testing Market Report 2026 - Global Outlook – By Type (Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test), By Application (Respiratory, Human Immunod...

Veterinary Infectious Disease Diagnostics Market Report 2026 - Global Outlook – By Infection Type (Viral Infections, Bacterial Infections, Parasitic Infections, Other Infections), By Animal Type (Companion Animal, Food-P...

In Vitro Diagnostics Enzymes Market Report 2026 - Global Outlook – By Enzyme Type (Proteases, Polymerase And Transcriptase, Ribonuclease, Other Enzyme Types), By Disease Type (Infectious Disease, Diabetes, Oncology, Card...

In Vitro Diagnostics (IVD) Quality Control Market Report 2026 - Global Outlook – By Product type (Quality Control Products, Data Management Solutions, Quality Assurance Services), By Manufacturer Type (IVD Instrument Man...

Infectious Disease Therapeutics Market Report 2026 - Global Outlook – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharm...

Viral Diagnostic Test Kits Market Report 2026 - Global Outlook – By Testing Approach (Traditional Tests, Rapid Test), By Test Type (Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcripta...

Hospital Acquired Infections Testing Kits Market Report 2026 - Global Outlook – By Product (Consumables And Reagents, Instruments), By Test Type (Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infec...

Frequently Asked Questions

How big is the Infectious Disease In Vitro Diagnostics Market?

The Infectious Disease In Vitro Diagnostics market was valued at $15.1 billion in 2025, increased to $16.13 billion in 2026, and is projected to reach $21.25 billion by 2030.

What is the Infectious Disease In Vitro Diagnostics market growth?

The global Infectious Disease In Vitro Diagnostics market is expected to grow at a CAGR of 7.1% from 2026 to 2035 to reach $21.25 billion by 2035.

Who are the key players in Infectious Disease In Vitro Diagnostics market?

Some Key Players in the Infectious Disease In Vitro Diagnostics market Include, F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare AG, bioMérieux SA, QIAGEN N.V., Becton Dickinson and Company, Hologic Inc., DiaSorin S.p.A., Meridian Bioscience, Quidel Corporation, Revvity Inc., OraSure Technologies Inc., Transasia Bio-Medicals Ltd., Randox Laboratories, Luminex Corporation, Wako Pure Chemical Industries Ltd., Bio-Rad Laboratories Inc., Trivitron Healthcare .

What is the anticipated growth trend for the Infectious Disease In Vitro Diagnostics market?

Major trend in this market includes: Developing Rapid Multi-Pathogen Detection Solutions To Enhance Timely Diagnosis And Expand Point-Of-Care Testing. For further insights on this market. request a sample here

Which region has the most growth potential in the Infectious Disease In Vitro Diagnostics market?

North America was the largest region in the infectious disease in vitro diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.